retatrutide obesity triple hormone receptor agonist Retatrutide, an investigational that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
























